Using flow cytometry to examine the cell cycle, we found that silencing KIFC1 could arrest the cell cycle in G2/M phase, suggesting that KIFC1 can be used as a biomarker for lung cancer diagnosis and treatment (Liu et al., 2016). This evidence concerns the gene KIFC1 and lung carcinoma.